|
2014 Journal Article Cell- and biomarker-based assays for predicting nephrotoxicityHuang, Johnny X., Blaskovich, Mark A. and Cooper, Matthew A. (2014). Cell- and biomarker-based assays for predicting nephrotoxicity. Expert Opinion on Drug Metabolism and Toxicology, 10 (12), 1621-1635. doi: 10.1517/17425255.2014.967681 |
|
2014 Journal Article Glycopeptide antibiotics: back to the futureButler, Mark S., Hansford, Karl A., Blaskovich, Mark A. T., Halai, Reena and Cooper, Matthew A. (2014). Glycopeptide antibiotics: back to the future. Journal of Antibiotics, 67 (9), 631-644. doi: 10.1038/ja.2014.111 |
|
2014 Journal Article An azido-oxazolidinone antibiotic for live bacterial cell imaging and generation of antibiotic variantsPhetsang, Wanida, Blaskovich, Mark A. T., Butler, Mark S., Huang, Johnny Xiao, Zuegg, Johannes, Mamidyala, Sreeman K., Ramu, Soumya, Kavanagh, Angela M. and Cooper, Matthew A. (2014). An azido-oxazolidinone antibiotic for live bacterial cell imaging and generation of antibiotic variants. Bioorganic and Medicinal Chemistry, 22 (16), 4490-4498. doi: 10.1016/j.bmc.2014.05.054 |
|
2014 Journal Article Anti-cooperative ligand binding and dimerisation in the glycopeptide antibiotic dalbavancinCheng, Mu, Ziora, Zyta M., Hansford, Karl A., Blaskovich, Mark A., Butler, Mark S. and Cooper, Matthew A. (2014). Anti-cooperative ligand binding and dimerisation in the glycopeptide antibiotic dalbavancin. Organic and Biomolecular Chemistry, 12 (16), 2568-2575. doi: 10.1039/c3ob42428f |
|
2013 Journal Article ChemInform abstract: lipoamino acids as major components of absorption promoters in drug deliveryZiora, Zyta M., Blaskovich, Mark A., Toth, Istvan and Cooper, Matthew A. (2013). ChemInform abstract: lipoamino acids as major components of absorption promoters in drug delivery. ChemInform, 44 (43), no-no. doi: 10.1002/chin.201343267 |
|
2013 Journal Article Antibiotics in the clinical pipeline in 2013Butler, Mark S., Blaskovich, Mark A. and Cooper, Matthew A. (2013). Antibiotics in the clinical pipeline in 2013. Journal of Antibiotics, 66 (10), 571-591. doi: 10.1038/ja.2013.86 |
|
2013 Journal Article Antibacterial serrulatane diterpenes from the Australian native plant Eremophila microthecaBarnes, Emma C., Kavanagh, Angela M., Ramu, Soumya, Blaskovich, Mark A., Cooper, Matthew A. and Davis, Rohan A. (2013). Antibacterial serrulatane diterpenes from the Australian native plant Eremophila microtheca. Phytochemistry, 93, 162-169. doi: 10.1016/j.phytochem.2013.02.021 |
|
2013 Other Outputs 3-Substituted-1,4-Diazepan-2-One Melanocortin-5 Receptor AntagonistsMark Arnold Thomas Blaskovich and Pater Joseph Cassidy (2013). 3-Substituted-1,4-Diazepan-2-One Melanocortin-5 Receptor Antagonists. US8440653 . |
|
2013 Other Outputs Methods of Modulating The Activity of the MC5 Receptor and Treatment of Conditions Related to This ReceptorMark Arnold Thomas Blaskovich and Peter Joseph Cassidy (2013). Methods of Modulating The Activity of the MC5 Receptor and Treatment of Conditions Related to This Receptor. US8377925. |
|
2013 Other Outputs “3-Aminoalkyl-1,4-Diazepan-2-One Melanocortin-5 Receptor AntagonistsMark Arnold Thomas Blaskovich and Peter Joseph Cassidy (2013). “3-Aminoalkyl-1,4-Diazepan-2-One Melanocortin-5 Receptor Antagonists. US8343958. |
|
2012 Journal Article Resolving biofilm infections: current therapy and drug discovery strategiesRanall, Max V., Butler, Mark S., Blaskovich, Mark A. and Cooper, Matthew A. (2012). Resolving biofilm infections: current therapy and drug discovery strategies. Current Drug Targets, 13 (11), 1375-1385. doi: 10.2174/138945012803530251 |
|
2012 Journal Article Lipoamino acids as major components of absorption promoters in drug deliveryZiora, Zyta M., Blaskovich, Mark A., Toth, Istvan and Cooper, Matthew A. (2012). Lipoamino acids as major components of absorption promoters in drug delivery. Current Topics in Medicinal Chemistry, 12 (14), 1562-1580. doi: 10.2174/156802612802652448 |
|
2012 Conference Publication New glycopeptidic antibiotics to combat multidrug resistant pathogensGong, Y., Muldoon, C. A., Premraj, R., Ziora, Z. M., Bradford, T. A., Cheng, M., Ramu, S., Huang, J. X., Kavanagh, A., Pelingon, R., Lee, J. C., Wong, K., Butler, M. S., Blaskovich, M. A. and Cooper, M. A. (2012). New glycopeptidic antibiotics to combat multidrug resistant pathogens. 32nd European Peptide Symposium, Athens, Greece, 2-7 September 2012. Chichester, West Sussex, United Kingdom: John Wiley & Sons. doi: 10.1002/psc.2449 |
|
2011 Other Outputs 3-Aminoalkyl-1,4-Diazepan-2-One Melanocortin-5 Receptor AntagonistsMark Arnold Thomas Blaskovich and Peter Joseph Cassidy (2011). 3-Aminoalkyl-1,4-Diazepan-2-One Melanocortin-5 Receptor Antagonists. US8008291. |
|
2010 Other Outputs Protein Tyrosine Phosphatase Inhibitors and Methods of Use ThereofMark Arnold Thomas Blaskovich, Ted Baughman, Thomas Little, Maher Qabar, Lauri Marie Schultz, Feng Hong, William Pratt, Gangadhar Nagula, Jennifer Lynn Gage and James Jeffry Howbert (2010). Protein Tyrosine Phosphatase Inhibitors and Methods of Use Thereof. US7829737. |
|
2010 Other Outputs Modulating the activity of a receptor comprising melanocortin-3 receptor or melanocortin-4 receptor, comprises exposing the receptor to 1,4-diazepan-2-one compoundsBlaskovich, Mark and CASSIDY P J (2010). Modulating the activity of a receptor comprising melanocortin-3 receptor or melanocortin-4 receptor, comprises exposing the receptor to 1,4-diazepan-2-one compounds. WO2010096854-A1. |
|
2010 Other Outputs Modulating activity of melanocortin-1 receptor, delivering active agent to melanocortin-1 receptor, and for treating condition e.g. hyperpigmentation, and pain involves exposing melanocortin-1 receptor to substituted (1,4)diazepane compoundBlaskovich, Mark and CASSIDY P J (2010). Modulating activity of melanocortin-1 receptor, delivering active agent to melanocortin-1 receptor, and for treating condition e.g. hyperpigmentation, and pain involves exposing melanocortin-1 receptor to substituted (1,4)diazepane compound. WO2010096853-A1. |
|
2009 Other Outputs New 1,4-diazepan-2-one derivatives useful for treating, preventing or controlling condition e.g. acne, seborrheic dermatitis, acne vulgaris, acne fulminans, inflammation, and cancersBLASKOVICH M A T and CASSIDY P J (2009). New 1,4-diazepan-2-one derivatives useful for treating, preventing or controlling condition e.g. acne, seborrheic dermatitis, acne vulgaris, acne fulminans, inflammation, and cancers. WO2009105823-A1. |
|
2009 Other Outputs New 1,4-diazepan-2-one derivatives useful for treating, preventing or controlling condition e.g. acne, seborrheic dermatitis, acne vulgaris, acne fulminans, inflammation, and cancersBLASKOVICH M A T and CASSIDY P J (2009). New 1,4-diazepan-2-one derivatives useful for treating, preventing or controlling condition e.g. acne, seborrheic dermatitis, acne vulgaris, acne fulminans, inflammation, and cancers. WO2009105825-A1. |
|
2009 Other Outputs Use of 1,4-diazepan-2-one derivatives for down-regulating activity of melanocortin-5 receptor and treating, preventing or controlling a condition e.g. acne, and seborrheic dermatitisBLASKOVICH M A T and CASSIDY P J, (2009). Use of 1,4-diazepan-2-one derivatives for down-regulating activity of melanocortin-5 receptor and treating, preventing or controlling a condition e.g. acne, and seborrheic dermatitis. WO2009105824-A1. |
